gi

A unique collection of 3000 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 280 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;

A unique collection of 2300 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);

TargetMol has established an anti-aging natural product library, which includes 195 natural products that have been experimentally verified to have anti-aging activity.

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1490 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 1220 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 1470 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 535 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 1600 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 1440 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;

120 well-chosen unique AMPK-targeted small molecules;

97 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

A unique collection of 2120 neurotransmitter receptor compounds, can be used for HTS and HCS screening;

A unique collection of 1120 bioactive small molecules with neuroprotective relevance for high throughput screening (HTS) and high content screening (HCS);

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 2010 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of 530 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 2405 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 435 pesticide-related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 5200 types of multi-target compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 500 compounds targeting serotonin receptors for high throughput screening and high content screening;